129 related articles for article (PubMed ID: 8475903)
1. The uses of molecular biology in hematopathology. Oncogenes as diagnostic markers in non-Hodgkin's malignant lymphoma.
Ratech H
Am J Clin Pathol; 1993 Apr; 99(4):381-4. PubMed ID: 8475903
[No Abstract] [Full Text] [Related]
2. Gastrointestinal non-Hodgkin's lymphoma.
Hickish T; Cunningham D
Baillieres Clin Gastroenterol; 1990 Mar; 4(1):191-200. PubMed ID: 2207350
[No Abstract] [Full Text] [Related]
3. Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
Nakamine H; Masih AS; Chan WC; Sanger WG; Armitage JO; Weisenburger DD
Leuk Lymphoma; 1993 May; 10(1-2):79-88. PubMed ID: 8374527
[TBL] [Abstract][Full Text] [Related]
4. Analysis of BCL2 and MYC expression in non-Hodgkin's lymphomas by in situ hybridization: correlation with chromosome translocations.
Murty VV; Ladanyi M; Houldsworth J; Mikraki V; Chaganti RS
Diagn Mol Pathol; 1992 Dec; 1(4):221-8. PubMed ID: 1342969
[TBL] [Abstract][Full Text] [Related]
5. Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.
Crossen PE; Morrison MJ; Colls BM
Br J Cancer; 1994 Apr; 69(4):759-61. PubMed ID: 7908219
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.
Chang H; Blondal JA; Benchimol S; Minden MD; Messner HA
Leuk Lymphoma; 1995 Sep; 19(1-2):165-71. PubMed ID: 8574164
[TBL] [Abstract][Full Text] [Related]
7. Genetic abnormalities in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
Merup M
Med Oncol; 1998 Jul; 15(2):79-88. PubMed ID: 9789214
[No Abstract] [Full Text] [Related]
8. Activation of MYCN in a case of non-Hodgkin's lymphoma.
Finnegan MC; Hammond DW; Hancock BW; Goyns MH
Leuk Lymphoma; 1995 Aug; 18(5-6):511-4. PubMed ID: 8528061
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective.
Gaidano G; Pastore C; Volpe G
Haematologica; 1995; 80(5):454-72. PubMed ID: 8566891
[TBL] [Abstract][Full Text] [Related]
10. The bcl-2 gene, follicular lymphoma, and Hodgkin's disease.
Cleary M; Rosenberg SA
J Natl Cancer Inst; 1990 May; 82(10):808-9. PubMed ID: 2185366
[No Abstract] [Full Text] [Related]
11. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.
Ngan BY; Chen-Levy Z; Weiss LM; Warnke RA; Cleary ML
N Engl J Med; 1988 Jun; 318(25):1638-44. PubMed ID: 3287162
[TBL] [Abstract][Full Text] [Related]
12. The molecular genetics of human non-Hodgkin's lymphoma.
Chenevix-Trench G
Cancer Genet Cytogenet; 1987 Aug; 27(2):191-213. PubMed ID: 3297303
[TBL] [Abstract][Full Text] [Related]
13. [Cytogenetic analysis in the definition and classification of non-Hodgkin's lymphomas].
Polito P; Perin T; Cilia A; Carbone A
Pathologica; 1994 Aug; 86(4):337-49. PubMed ID: 7708433
[TBL] [Abstract][Full Text] [Related]
14. Amino acid substitution at position 13 of the N-ras gene in a non-Hodgkin's lymphoma patient.
Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
Haematol Blood Transfus; 1987; 31():172-4. PubMed ID: 3327770
[No Abstract] [Full Text] [Related]
15. Chromosomal translocations and their role in the pathogenesis of non-Hodgkin's lymphomas.
Vega F; Orduz R; Medeiros LJ
Pathology; 2002 Oct; 34(5):397-409. PubMed ID: 12408337
[TBL] [Abstract][Full Text] [Related]
16. Molecular biology and cytogenetics of non-Hodgkin's lymphoma in children.
Williams SA; Suen Y; Cairo MS
Semin Diagn Pathol; 1995 Nov; 12(4):335-41. PubMed ID: 8578028
[TBL] [Abstract][Full Text] [Related]
17. The cellular and molecular heterogeneity of the aggressive non-Hodgkin's lymphomas.
Howard OM; Shipp MA
Curr Opin Oncol; 1998 Sep; 10(5):385-91. PubMed ID: 9800106
[TBL] [Abstract][Full Text] [Related]
18. [Chromosome aberrations and malignant lymphomas].
Fonatsch C; Gradl G
Onkologie; 1987 Aug; 10(4):206-16. PubMed ID: 3313144
[TBL] [Abstract][Full Text] [Related]
19. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
[TBL] [Abstract][Full Text] [Related]
20. Oncogenes, growth factors, and prognostic indicators in colorectal cancer.
Rowley S; Newbold M; Neoptolemos JP
Surg Annu; 1992; 24 Pt 2():59-85. PubMed ID: 1440150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
